Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Furio Colivicchi

Showing results (181-190 of 486) with videos related to

Pageof 49
Sort By:
Frontiers in Cardiovascular Medicine|May 2, 2022
Clinical Impact and Prognostic Role of Triglyceride to High-Density Lipoprotein Cholesterol Ratio in Patients With Chronic Coronary Syndromes at Very High Risk: Insights From the START StudyLeonardo De Luca, Pier Luigi Temporelli, Furio Colivicchi, et al.
International Journal of Cardiology|May 30, 2020
Current lipid lowering treatment and attainment of LDL targets recommended by ESC/EAS guidelines in very high-risk patients with established atherosclerotic cardiovascular disease: Insights from the START registryLeonardo De Luca, Marcello Arca, Pier Luigi Temporelli, et al.
Journal of Clinical Medicine|October 14, 2022
Superiority of Direct Oral Anticoagulants over Vitamin K Antagonists in Oncological Patients with Atrial Fibrillation: Analysis of Efficacy and Safety OutcomesIris Parrini, Fabiana Lucà, Carmelo Massimiliano Rao, et al.
Giornale Italiano Di Cardiologia (2006)|July 20, 2019
[ANMCO Position paper: New perspectives on the role of n-3 polyunsaturated fatty acids in cardiovascular prevention]Furio Colivicchi, Fabio Vagnarelli, Pasquale Caldarola, et al.
International Journal of Cardiology|May 31, 2018
Major bleeding with old and novel oral anticoagulants: How to manage it. Focus on reversal agentsStefania Angela Di Fusco, Fabiana Lucà, Manuela Benvenuto, et al.
International Journal of Environmental Research and Public Health|August 29, 2020
The Perceived Health Status from Young Adults to Elderly: Results of the MEHM Questionnaire within the CUORE Project Survey 2008-2012Claudia Giacomozzi, Luigi Palmieri, Lidia Gargiulo, et al.
International Journal of Cardiology|June 2, 2018
Major bleeding with old and novel oral anticoagulants: How to manage it. Focus on general measuresStefania Angela Di Fusco, Fabiana Lucà, Manuela Benvenuto, et al.
Giornale Italiano Di Cardiologia (2006)|September 27, 2021
[ANMCO Position paper: Double, triple or quadruple therapy for heart failure with reduced ejection fraction. Current evidence and new strategies]Andrea Di Lenarda, Giuseppe Di Tano, Manlio Cipriani, et al.
Journal of Clinical Medicine|May 11, 2024
Prevention and Risk Assessment of Cardiac Device Infections in Clinical PracticeAndrea Matteucci, Carlo Pignalberi, Claudio Pandozi, et al.
Reviews in Cardiovascular Medicine|September 26, 2021
Current management and prognosis of patients with recurrent myocardial infarctionLeonardo De Luca, Luca Paolucci, Annunziata Nusca, et al.
Pageof 49

Showing results (181-190 of 486) with videos related to

Sort By:
Pageof 49
Frontiers in Cardiovascular Medicine|May 2, 2022
Clinical Impact and Prognostic Role of Triglyceride to High-Density Lipoprotein Cholesterol Ratio in Patients With Chronic Coronary Syndromes at Very High Risk: Insights From the START StudyLeonardo De Luca, Pier Luigi Temporelli, Furio Colivicchi, et al.
International Journal of Cardiology|May 30, 2020
Current lipid lowering treatment and attainment of LDL targets recommended by ESC/EAS guidelines in very high-risk patients with established atherosclerotic cardiovascular disease: Insights from the START registryLeonardo De Luca, Marcello Arca, Pier Luigi Temporelli, et al.
Journal of Clinical Medicine|October 14, 2022
Superiority of Direct Oral Anticoagulants over Vitamin K Antagonists in Oncological Patients with Atrial Fibrillation: Analysis of Efficacy and Safety OutcomesIris Parrini, Fabiana Lucà, Carmelo Massimiliano Rao, et al.
Giornale Italiano Di Cardiologia (2006)|July 20, 2019
[ANMCO Position paper: New perspectives on the role of n-3 polyunsaturated fatty acids in cardiovascular prevention]Furio Colivicchi, Fabio Vagnarelli, Pasquale Caldarola, et al.
International Journal of Cardiology|May 31, 2018
Major bleeding with old and novel oral anticoagulants: How to manage it. Focus on reversal agentsStefania Angela Di Fusco, Fabiana Lucà, Manuela Benvenuto, et al.
International Journal of Environmental Research and Public Health|August 29, 2020
The Perceived Health Status from Young Adults to Elderly: Results of the MEHM Questionnaire within the CUORE Project Survey 2008-2012Claudia Giacomozzi, Luigi Palmieri, Lidia Gargiulo, et al.
International Journal of Cardiology|June 2, 2018
Major bleeding with old and novel oral anticoagulants: How to manage it. Focus on general measuresStefania Angela Di Fusco, Fabiana Lucà, Manuela Benvenuto, et al.
Giornale Italiano Di Cardiologia (2006)|September 27, 2021
[ANMCO Position paper: Double, triple or quadruple therapy for heart failure with reduced ejection fraction. Current evidence and new strategies]Andrea Di Lenarda, Giuseppe Di Tano, Manlio Cipriani, et al.
Journal of Clinical Medicine|May 11, 2024
Prevention and Risk Assessment of Cardiac Device Infections in Clinical PracticeAndrea Matteucci, Carlo Pignalberi, Claudio Pandozi, et al.
Reviews in Cardiovascular Medicine|September 26, 2021
Current management and prognosis of patients with recurrent myocardial infarctionLeonardo De Luca, Luca Paolucci, Annunziata Nusca, et al.
Pageof 49